We are thrilled to welcome Heather to the Avalyn team and to her new role as Board Chair,” said Lyn Baranowski, chief executive officer of Avalyn. “As we look ahead, we are excited to tap into Heather ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

As physicians we take an oath to do no harm, yet are trapped providing care in a system that leaves patients confined and at ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Spirometry, a type of pulmonary ... lungs to fully expand. This includes obesity, scoliosis (abnormal curvature of the spine), diaphragmatic paralysis, and pleural effusion. Intra-thoracic restriction ...

What is cystic fibrosis liver disease? Liver disease associated with cystic fibrosis (CF) has been increasingly diagnosed during recent years, most likely due to the combined effect of systematic ...

Some airline passengers are gross. I pay my fare like everyone else and always wait for my turn to board. Does it matter if I get onto the flight five minutes after somebody else? Why do people ...

“This exciting collaboration with GSK will help … make meaningful progress in the treatment of chronic lung diseases like pulmonary fibrosis,” Darrell Kotton, MD, CReM’s founding director and a ...

1 State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary ... fibrosis and open new avenues for therapy. Cytoskeletal remodeling impacts fibrosis ...